Crossref
Impact of AWGS 2025 on Pre-Transplant Sarcopenia Classification and Prognostic Relevance in Allogeneic Hematopoietic Stem Cell Transplantation
BLOOD CELL THERAPY / The official journal of APBMT · 2026 · 9 (4)
DOI: 10.31547/bct-2026-018 ↗Kurz gefasst
Fachartikel in der Zeitschrift BLOOD CELL THERAPY / The official journal of APBMT, 2026.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). Impact of AWGS 2025 on Pre-Transplant Sarcopenia Classification and Prognostic Relevance in Allogeneic Hematopoietic Stem Cell Transplantation. BLOOD CELL THERAPY / The official journal of APBMT, 9(4). https://doi.org/10.31547/bct-2026-018
Vancouver
Impact of AWGS 2025 on Pre-Transplant Sarcopenia Classification and Prognostic Relevance in Allogeneic Hematopoietic Stem Cell Transplantation. BLOOD CELL THERAPY / The official journal of APBMT. 2026;9(4). doi:10.31547/bct-2026-018
BibTeX
@article{euvimed2026,
title = {Impact of AWGS 2025 on Pre-Transplant Sarcopenia Classification and Prognostic Relevance in Allogeneic Hematopoietic Stem Cell Transplantation},
journal = {BLOOD CELL THERAPY / The official journal of APBMT},
year = {2026},
volume = {9},
number = {4},
doi = {10.31547/bct-2026-018}
}
EUVIMED